Spruce Biosciences SPRB
NASDAQ SPRB
$42.14 +0.91 (+2.21%)
As of: Oct 21, 2026 · 3:13 PM EDT

Spruce Biosciences (SPRB) Change in Receivables (2023)

Updated

Spruce Biosciences (SPRB) recorded Change in Receivables of $15 million in Q1 2023.

Analysis

Spruce Biosciences (SPRB) Change in Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,137.48 Bn 1,106.07 Bn 19.71 Bn -
2 Johnson & Johnson 618.81 Bn 537.34 Bn 17.26 Bn 1.35 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn 1.37 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn -
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn -
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn -
7 Amgen 236.67 Bn 192.07 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.16 Bn 165.36 Bn 6.22 Bn 333.00 Mn
9 Pfizer 169.69 Bn 116.34 Bn 10.94 Bn -
10 Spruce Biosciences 102.45 Mn -107.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 15.00 Mn
API Access

Spruce Biosciences Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=SPRB&period=max&api_key=YOUR_API_KEY